# Koselugo (selumetinib sulfate) PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/selumetinib

> The FDA approved Koselugo (selumetinib sulfate), sponsored by ASTRAZENECA PLC (AZN), on April 10, 2020.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Key facts

| Field | Value |
| --- | --- |
| Drug | Koselugo (selumetinib sulfate) |
| Codes |  |
| Sponsor | ASTRAZENECA PLC (AZN) https://sec-api.dev/companies/azn/catalysts |
| Indications |  |
| Modality |  |
| FDA designations | priority review |

## Timeline

### April 10, 2020: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA213756 ORIG-1 (Type 1 - New Molecular Entity): submission_status AP, submission_status_date 20200410, review_priority PRIORITY; sponsor_name ASTRAZENECA; product KOSELUGO (SELUMETINIB SULFATE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA213756%22

### January 24, 2024: label expansion decision

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA213756 SUPPL-4 (Efficacy): submission_status AP, submission_status_date 20240124, review_priority STANDARD; sponsor_name ASTRAZENECA; product KOSELUGO (SELUMETINIB SULFATE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA213756%22

### September 10, 2025: label expansion decision

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA213756 SUPPL-5 (Efficacy): submission_status AP, submission_status_date 20250910, review_priority PRIORITY; sponsor_name ASTRAZENECA; product KOSELUGO (SELUMETINIB SULFATE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA213756%22

### November 19, 2025: label expansion decision

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA213756 SUPPL-6 (Efficacy): submission_status AP, submission_status_date 20251119, review_priority STANDARD; sponsor_name ASTRAZENECA; product KOSELUGO (SELUMETINIB SULFATE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA213756%22

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/selumetinib.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Koselugo (selumetinib sulfate) PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/selumetinib

```bibtex
@misc{secapidev_pdufa_selumetinib_20261116,
  title        = {Koselugo (selumetinib sulfate) PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/selumetinib}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_selumetinib_20261116","title":"Koselugo (selumetinib sulfate) PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/selumetinib","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
